BioDelivery Sciences International, Inc.
BDSI · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $167 | $156 | $111 | $56 |
| % Growth | 6.5% | 40.5% | 100.2% | – |
| Cost of Goods Sold | $23 | $25 | $22 | $16 |
| Gross Profit | $143 | $132 | $90 | $40 |
| % Margin | 86% | 84.2% | 80.6% | 71.6% |
| R&D Expenses | $0 | $0 | $0 | $5 |
| G&A Expenses | $0 | $0 | $0 | $59 |
| SG&A Expenses | $106 | $99 | $86 | $59 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | -$0 |
| Operating Expenses | $106 | $99 | $86 | $64 |
| Operating Income | $37 | $33 | $4 | -$24 |
| % Margin | 22.3% | 21.1% | 3.4% | -42.5% |
| Other Income/Exp. Net | -$8 | -$7 | -$19 | -$10 |
| Pre-Tax Income | $30 | $26 | -$15 | -$34 |
| Tax Expense | -$55 | $0 | $0 | $0 |
| Net Income | $85 | $26 | -$15 | -$34 |
| % Margin | 50.9% | 16.4% | -13.7% | -60.9% |
| EPS | 0.82 | 0.26 | -0.18 | -0.54 |
| % Growth | 215.4% | 244.4% | 66.7% | – |
| EPS Diluted | 0.82 | 0.24 | -0.18 | -0.54 |
| Weighted Avg Shares Out | 103 | 100 | 83 | 63 |
| Weighted Avg Shares Out Dil | 103 | 105 | 83 | 63 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $7 | $7 | $19 | $10 |
| Depreciation & Amortization | $7 | $8 | $9 | $6 |
| EBITDA | $45 | $40 | $13 | -$18 |
| % Margin | 26.7% | 25.9% | 11.3% | -31.9% |